AI Takes Aim at Precision Medicine, Surgery, Data Analysis, and More | StartUp Health Insights: Week of Mar 19, 2024

Get ready for AI-powered diagnostics, AI-guided custom protein creation, and conversational AI call centers. This week's funding news reveals exciting possibilities for the future of healthcare.

This week’s reported health innovation funding included:

Zephyr AI, a Tysons Corner, VA-based company developing AI solutions to democratize precision medicine, raised $111M from Revolution Growth, Eli Lilly & Company, Jeff Skoll, EPIQ Capital Group, and others. <source>

Carlsmed, a Carlsbad, CA-based AI-enabled personalized surgery medtech company, raised $52.5M led by B Capital and U.S. Venture Partners.<source>

Empathy, a New York, NY-based company providing a support system for loss, raised $47M led by Index Ventures, with participation from General Catalyst, Entrée Capital, Latitude, and Brewer Lane, plus strategic investments from life insurance carriers Allianz, MassMutual Ventures, MetLife, New York Life Ventures, Securian Financial, and Sumitomo. <source>

HiLabs, a Bethesda, MD-based company that sells AI-powered data analysis tools to health plans, raised $39M led by Eight Roads and Denali Growth Partners, with participation from F-Prime Capital. <source>

Re­la­tion Ther­a­peu­tics, a London, UK-based ‘Chat­G­PT for DNA,’ raised $35M from Nvidia’s NVen­tures, DCVC, Deer­field Man­age­ment Com­pa­ny, Khosla Ven­tures, Jonathan Mil­ner, ARK In­vest, and Mag­net­ic Ven­tures. <source>

Pi Health, a Cambridge, MA-based oncology-focused health tech and clinical research company focused on global access to innovative medicines and clinical trials, raised over $30M led by AlleyCorp and Obvious Ventures, with participation from Invus Capital and leaders in oncology. <source>

X-Therma, a San Francisco, CA-based biotechnology company developing a platform for regenerative medicine and organ preservation, raised $22.4M led by Starling Locke Capital and Lorea, with participation from new and existing investors. <source>

Anima, a London, UK-based provider of a care enablement platform, raised $12M led by Molten Ventures, with participation from Hummingbird Ventures, Amino Collective, Y Combinator, and angel investors. <source>

Tierra Biosciences, a San Leandro, CA-based developer of a platform for AI-guided, custom protein synthesis to help pharma organizations develop new proteins, raised $11.4M led by Material Impact, with participation from Prosus Ventures, In-Q-Tel (IQT), Hillspire, Freeflow Ventures, Creative Ventures, and Social Capital. <source>

Proscia, a Philadelphia, PA-based provider of digital pathology software, raised $9M led by Highline Capital Management and Triangle Peak Partners, with participation from Alpha Intelligence Capital, Scale Venture Partners, Hitachi Ventures, and others. <source>

Bone Health Technologies, a Redwood City, CA-based health tech company focused on osteoporosis, raised $5M from Esplanade Ventures, Berkeley Catalyst Fund, and Terumo Medical. <source>

Sugar.fit, a Bangalore, India-based health tech startup focused on Type 2 diabetes and prediabetes, raised$5M led by B Capital, with participation from MassMutual Ventures, Tanglin Venture Partners, Endiya Partners, and Cure.Fit. <source>

Nest Health, a New Orleans, LA-based value-based whole-family healthcare provider, raised over $4M led by SpringTide, with participation from Alumni Ventures, Ochsner Ventures, and others. <source>

Assort Health, a San Francisco, CA-based developer of conversational AI for call center operations, raised $3.5M led by Quiet Capital, with participation from Four Acres Capital, Pioneer Fund, Strategic Waterfall Partners, and Tau Ventures. <source>

Neupulse, a Nottingham, UK-based health tech company focused on patients with Tourette's Syndrome, raised $3.2M led by Eos Advisory. <source>

ThinkSono, a London, UK-based medical tech company specializing in ultrasound AI guidance solutions, raised £2.1M ($2.7M) led by id4 ventures, with participation from Brandenburg Kapital, Calm Storm Ventures, Dubai Angel Investors, CrowdCube, Cur8 Capital, and angel investors and vascular surgery clinicians. <source>

Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.


Call for Alzheimer’s Innovation

With support from the Alzheimer’s Drug Discovery Foundation (ADDF) and Gates Ventures, we’ve launched a new global initiative created to develop a collaborative innovation community alongside leading companies, research teams, and stakeholders with a mission to accelerate progress in prevention, diagnosis, and management of Alzheimer’s disease and related dementias. Learn more and apply for an Alzheimer’s Moonshot Fellowship.

Call for T1D Innovation

We’re in the final phase of building our Type 1 Diabetes Moonshot Community; there are just a few more fellowships available. Apply today to join a community of 30+ inspiring T1D companies and collaborate with our amazing Impact Board. Learn more and apply for a T1D Fellowship.

Become a Health Moonshot Champion

Health moonshots are fueled by passionate families, foundations, and industry organizations committed to achieving health moonshots. Learn how you can join other champions of the T1D Moonshot or one of our other global health moonshots.

Follow us on social media for daily updates on Health Transformers: Twitter, LinkedIn, Facebook, and Instagram.

Previous
Previous

Jerry Levin: A Reflection by Esther Dyson

Next
Next

Novel Interventions in Children’s Healthcare (NICH) Serves Vulnerable Youth Struggling with Type 1 Diabetes